Purchase Order 36C24226P0879

<p>Veterans Integrated Service Network 2 issued a purchase order to Covermymeds Pharmacy LLC on May 1, 2026, for $16,331.35 to supply Pomalyst 3mg prescription medication for the Brooklyn Veterans Affairs Medical Center pharmacy service. Performance is located in Memphis, Tennessee. The order is firm fixed price with an ultimate completion date of June 1, 2026.</p>

Covermymeds Pharmacy LLC was awarded a firm fixed price purchase order by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, for the supply of Pomalyst 4 mg capsules. The contract, awarded on April 17, 2026, carries a ceiling value of $16,421.95 and is scheduled for ultimate completion by July 17, 2026. The pharmaceutical products will be delivered to the place of performance in Memphis, Tennessee. This purchase order represents a...

<p>The Defense Logistics Agency issued a $16,080.25 delivery order to Amerisourcebergen Drug Corp on May 13, 2026, for Pomalyst 2 mg capsules (21-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion is June 4, 2026. The order carries a firm fixed price and no set-aside.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Pomalyst (pomalidomide) 1 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $114,147.61, is set to be completed by July 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's demonstrated...

Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on July 15, 2026, for Pomalidomide (Pomalyst) 4 mg capsules with a ceiling value of $16,421.95 under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The call closes July 21, 2026. Place of performance is Memphis, Tennessee. Bristol-Myers Squibb supplies specialized oncology and hematology pharmaceuticals to the Department of Veterans Affairs on a full-and-open basis with no small...

The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on July 31, 2026, for POMALYST 3 MG with a ceiling value of $10,887.57 under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Federal Supply Schedule. Place of performance is Memphis, Tennessee. The call carries an ultimate completion date of August 4, 2026. Pricing is firm fixed price. This order represents a narrow pharmaceutical supply call within Bristol-Myers Squibb's...

Bristol-Myers Squibb Company was awarded a delivery order valued at $10,887.52 on April 16, 2026, for the supply of POMALYST 3 MG to Veterans Integrated Service Network 5 (VISN 5), with an ultimate completion date of April 23, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, a master schedule vehicle with a substantial ceiling...

The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on June 11, 2026, with a ceiling value of $16,767.72. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a multiple-award IDIQ with the VA carrying a $12.278 billion ceiling through April 30, 2029. The call procures POMALYST 2 MG, a specialty oncology pharmaceutical. Place of performance is Memphis, Tennessee. The call...

Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company under the Pharmaceuticals and Drugs (FSS-61-IB) federal supply schedule, with a ceiling value of $232,761.28 and an award date of February 17, 2026. The call covers MAVACAMTEN (CAMZYOS) 5 mg and POMALIDOMIDE (POMALYST) 2 mg, pharmaceutical products for specialty oncology treatment. Performance occurs at Memphis, Tennessee, with ultimate completion by September 30, 2026. The call is firm fixed price with no...

This federal contract award is for the delivery of POMALYST 1 MG CAPSULE 21S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 14, 2024 with a ceiling value of $68,816.28 and a completion date of June 5, 2024. The award is a delivery order contract, with a firm fixed price pricing type. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...